Literature DB >> 4425855

Host resistance in relation to survival in breast cancer.

M Di Paola, L Angelini, A Bertolotti, S Colizza.   

Abstract

The degree of lymphocytic infiltration in and around breast tumours together with sinus histiocytosis and follicular hyperplasia in regional lymph nodes has been studied in 310 cases of breast cancer treated with standard radical mastectomy. The presence of these features was regarded as evidence of host resistance against the tumour and made possible the division of patients into three classes-no or poor reaction, good reaction, and strong reaction. The grading was shown to have a close correlation with prognosis. The relationship between host defensive factor grading and malignancy, nodal metastases, and survival was also examined. The results support the hypothesis that prognosis in breast cancer is closely related to a histological picture of cell-mediated immunity against the tumour.

Entities:  

Mesh:

Year:  1974        PMID: 4425855      PMCID: PMC1612263          DOI: 10.1136/bmj.4.5939.268

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Pathologic evaluation of breast carcinoma.

Authors:  M Wernicke
Journal:  Am J Surg       Date:  1972-03       Impact factor: 2.565

2.  Studies concerning the regional lymph node in cancer. VI. Correlation of lymphocyte transformation of regional node cells and some histopathologic discriminants.

Authors:  E R Fisher; E Saffer; B Fisher
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

3.  A new sign of favorable prognosis in mammary cancer: hyperplastic reactive lymph nodes in the apex of the axilla.

Authors:  J W Berg; A G Huvos; L M Axtell; G F Robbins
Journal:  Ann Surg       Date:  1973-01       Impact factor: 12.969

4.  Radical mastectomy for mammary carcinoma.

Authors:  H R Butcher
Journal:  Ann Surg       Date:  1969-12       Impact factor: 12.969

5.  Radical mastectomy for mammary carcinoma.

Authors:  C D Haagensen; E Cooley
Journal:  Ann Surg       Date:  1969-12       Impact factor: 12.969

6.  Radiation-induced lymphocyte-immune deficiency. A factor in the increased visceral metastases and decreased hormonal responsiveness of breast cancer.

Authors:  K K Meyer
Journal:  Arch Surg       Date:  1970-08

7.  Nuclear grade and sinus histiocytosis in cancer of the breast.

Authors:  S J Kister; S C Sommers; C D Haagenses; G H Friedell; E Cooley; A Varma
Journal:  Cancer       Date:  1969-03       Impact factor: 6.860

8.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

9.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

10.  Immunological significance of the morphological changes in lymph nodes draining breast cancer.

Authors:  O T Anastassiades; D M Pryce
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

View more
  10 in total

1.  Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.

Authors:  R Schoorl; A B Riviere; A E Borne; T M Feltkamp-Vroom
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

2.  The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy.

Authors:  Claudia Urueña; Paola Lasso; David Bernal-Estevez; Diego Rubio; Ana Janeth Salazar; Mercedes Olaya; Alfonso Barreto; Mauricio Tawil; Lilian Torregrosa; Susana Fiorentino
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

Review 3.  The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.

Authors:  T H Stewart; S C Tsai
Journal:  Clin Exp Metastasis       Date:  1993-07       Impact factor: 5.150

4.  Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival.

Authors:  H O Wintzer; W Bohle; S von Kleist
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 5.  Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment.

Authors:  Sarah Jenkins; Robert Wesolowski; Margaret E Gatti-Mays
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

Review 6.  Managing Expectations in the Transition to Proof of Concept Studies.

Authors:  Thomas Kieber-Emmons; Issam Makhoul; Angela Pennisi; Eric R Siegel; Peter D Emanuel; Bejotaloh Monzavi-Karbassi; Zenon Steplewski; J Thaddeus Beck; Laura F Hutchins
Journal:  Rev Recent Clin Trials       Date:  2017

7.  Myeloid cells in circulation and tumor microenvironment of breast cancer patients.

Authors:  Salman M Toor; Azharuddin Sajid Syed Khaja; Haytham El Salhat; Issam Faour; Jihad Kanbar; Asif A Quadri; Mohamed Albashir; Eyad Elkord
Journal:  Cancer Immunol Immunother       Date:  2017-03-10       Impact factor: 6.968

Review 8.  If we build it they will come: targeting the immune response to breast cancer.

Authors:  Margaret E Gatti-Mays; Justin M Balko; Sofia R Gameiro; Harry D Bear; Sangeetha Prabhakaran; Jami Fukui; Mary L Disis; Rita Nanda; James L Gulley; Kevin Kalinsky; Houssein Abdul Sater; Joseph A Sparano; David Cescon; David B Page; Heather McArthur; Sylvia Adams; Elizabeth A Mittendorf
Journal:  NPJ Breast Cancer       Date:  2019-10-29

9.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Authors:  O Eremin; R R Coombs; J Ashby
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

Review 10.  Breast cancer survival among young women: a review of the role of modifiable lifestyle factors.

Authors:  Darren R Brenner; Nigel T Brockton; Joanne Kotsopoulos; Michelle Cotterchio; Beatrice A Boucher; Kerry S Courneya; Julia A Knight; Ivo A Olivotto; May Lynn Quan; Christine M Friedenreich
Journal:  Cancer Causes Control       Date:  2016-03-12       Impact factor: 2.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.